Vaccine slows progression of skeletal muscle disorder

May 13, 2009

A potential vaccine for Alzheimer's disease also has been shown in mice to slow the weakening of muscles associated with inclusion body myositis, a disorder that affects the elderly.

The finding brings new hope for IBM patients with weakness, inflammation or of muscles in their fingers, wrists, forearms or quadriceps. There is no cure for IBM, nor is there an effective treatment, according to the National Institutes of Health.

"The immunization wasn't a complete fix, but it significantly slowed the deterioration of motor function in our IBM mice," said Frank LaFerla, director of UC Irvine's Institute for and . "I hope our discovery leads to clinical trials and, eventually, a vaccine for people suffering from or at risk for IBM."

Study results appear Wednesday, May 13, in The Journal of Neuroscience.

LaFerla and assistant project scientist Masashi Kitazawa tested the vaccine on 1-year-old mice with high levels of a protein called in their skeletal muscle tissue - a characteristic feature of IBM.

After three months of treatment, the mice were producing antibodies against beta amyloid and had less of the protein in their muscles. Levels of oligomeric beta amyloid - a more toxic form - also were reduced.

"It appears the antibodies helped remove beta amyloid or blocked its accumulation in so they could stay healthy longer," Kitazawa said.

Immunotherapy approaches such as vaccination are being extensively studied for Alzheimer's in humans. In that disease, beta amyloid accumulates in the brain and leads to the creation of senile plaques, one of two signature Alzheimer's lesions. Although immunotherapy has shown some benefit in human clinical trials, there are significant safety concerns. For example, about 6 percent of people develop encephalitis, or .

LaFerla thinks it's unlikely IBM patients would develop encephalitis: "With IBM, brain integrity is not compromised like it is with Alzheimer's. We should be cautious, but there's little reason to assume IBM patients would have the same problem."

Source: University of California - Irvine

Explore further: French firm announces multiple sclerosis drug breakthrough

Related Stories

Can tomatoes carry the cure for Alzheimer's?

Jul 08, 2008

The humble tomato could be a suitable carrier for an oral vaccine against Alzheimer's disease, according to HyunSoon Kim from the Korea Research Institute of Bioscience and Biotechnology (KRIBB) in Korea and colleagues from ...

Anti-inflammatory drug blocks brain plaques

Jun 24, 2008

Brain destruction in Alzheimer's disease is caused by the build-up of a protein called amyloid beta in the brain, which triggers damaging inflammation and the destruction of nerve cells. Scientists had previously shown that ...

Potatoes may hold key to Alzheimer's treatment

Aug 15, 2008

A virus that commonly infects potatoes bears a striking resemblance to one of the key proteins implicated in Alzheimer's disease (AD), and researchers have used that to develop antibodies that may slow or prevent the onset ...

Vitamin B3 reduces Alzheimer's symptoms, lesions

Nov 04, 2008

An over-the-counter vitamin in high doses prevented memory loss in mice with Alzheimer's disease, and UC Irvine scientists now are conducting a clinical trial to determine its effect in humans.

Recommended for you

Team makes breakthrough in understanding Canavan disease

15 hours ago

UC Davis investigators have settled a long-standing controversy surrounding the molecular basis of an inherited disorder that historically affected Ashkenazi Jews from Eastern Europe but now also arises in other populations ...

Finding the body clock's molecular reset button

18 hours ago

An international team of scientists has discovered what amounts to a molecular reset button for our internal body clock. Their findings reveal a potential target to treat a range of disorders, from sleep ...

A 'GPS' to navigate the brain's neuronal networks

19 hours ago

In new research published today by Nature Methods, scientists from the Hebrew University of Jerusalem and Harvard University have announced a "Neuronal Positioning System" (NPS) that maps the circuitry of the ...

Neurons constantly rewrite their DNA

19 hours ago

Johns Hopkins scientists have discovered that neurons are risk takers: They use minor "DNA surgeries" to toggle their activity levels all day, every day. Since these activity levels are important in learning, ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.